Yummy or too sour? Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock
JP Morgan raised the price target for the Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) stock from “an Underweight” to “a Neutral”. The rating was released on March 08, 2024, according to finviz. We previously noted in another research note published on February 12, 2024 by Piper Sandler that upgraded the stock from a Neutral to […]
